Accelerate Diagnostics, Inc. / Fundamentals
Income statement
- Net revenue
€10.08M - Cost of goods sold
€7.75M - Gross profit
€2.33M - SG&A expenses
€18.37M - R&D expenses
€14.38M - EBITDA
-€28.93M - D&A
€2.95M - EBIT
-€30.42M - Interest expenses
€11.30M - EBT
-€43.17M - Tax expenses
€645.06K - Net income
-€43.12M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€20.93M - Changes in working capital
-€0.00 - Operating cash flow
-€20.84M - Capex
€438.53K - Other investing cash flow
-€438.53K - Net investing cash flow
-€438.53K - Total cash dividends paid
€0.00 - Issuance of common stock
-€0.00 - Debt repayment
-€1.25M - Other financing cash flow
€24.56M - Net financing cash flow
€23.31M - Foreign exchange effects
€525.54K - Net change in cash
€2.55M - Cash at end of period
€13.01M - Free cash flow
-€20.41M
Balance sheet
- Cash and cash equivalents
€13.01M - Cash and short-term investments
€14.04M - Total receivables
€1.75M - Inventory
€2.46M - Other current assets
€906.35K - Total current assets
€19.16M - Property, plant & equipment
€5.01M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€430.77K - Total non-current assets
€5.44M - Total assets
€24.60M - Accounts payable
€4.17M - Short-term debt
€14.23M - Other current liabilities
€7.07M - Total current liabilities
€26.88M - Long-term debt
€40.35M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€5.65M - Total non-current liabilities
€46.00M - Total liabilities
€72.88M - Common stock
€0.00 - Retained earnings
€0.00 - Other equity
-€5.17K - Total equity
-€48.28M - Total liabilities and shareholders' equity
€24.60M
Company information
- Market capitalization
€733.47K - Employees
107 - Enterprise Value
€52.34M
Company ratios
- Gross margin
-
23.1% Much worse than peer group: 61.6% - EBITDA margin
-
-287.0% Much worse than peer group: -12.5% - EBIT margin
-
-301.9% Much worse than peer group: -18.1% - EBT margin
-
-428.4% Much worse than peer group: 5.7% - Net margin
-
-427.8% Much worse than peer group: -22.0% - ROE
-
89.3% Much better than peer group: 32.7% - ROA
-
-175.3% Much worse than peer group: -3.3% - Asset turnover
-
41.0% Much worse than peer group: 66.2% - FCF margin
-
-211.2% Much worse than peer group: -13.7% - FCF yield
-2,901.7% - Efficiency ratio
387.0% - Net sales per employee
-
€94.19K - Net income per employee
-
-€402.96K